ADAG
Price
$4.49
Change
-$0.30 (-6.26%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
295.34M
59 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$5.88
Change
+$0.07 (+1.20%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
184.68M
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADAG vs LENZ

ADAG vs LENZ Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADAG vs. LENZ commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (ADAG: $4.19 vs. LENZ: $5.82)
Brand notoriety: ADAG and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 227% vs. LENZ: 204%
Market capitalization -- ADAG: $295.34M vs. LENZ: $184.68M
ADAG [@Biotechnology] is valued at $295.34M. LENZ’s [@Biotechnology] market capitalization is $184.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ADAG is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 5 TA indicator(s) are bullish while LENZ’s TA Score has 4 bullish TA indicator(s).

  • ADAG’s TA Score: 5 bullish, 3 bearish.
  • LENZ’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ADAG is a better buy in the short-term than LENZ.

Price Growth

ADAG (@Biotechnology) experienced а +1.70% price change this week, while LENZ (@Biotechnology) price change was +5.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Reported Earning Dates

ADAG is expected to report earnings on Sep 02, 2026.

LENZ is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADAG($295M) has a higher market cap than LENZ($185M). ADAG YTD gains are higher at: 121.693 vs. LENZ (-63.625). ADAG has higher annual earnings (EBITDA): -29.17M vs. LENZ (-117.98M). LENZ has more cash in the bank: 258M vs. ADAG (62.8M). LENZ has less debt than ADAG: LENZ (673K) vs ADAG (6.85M). LENZ has higher revenues than ADAG: LENZ (21M) vs ADAG (103K).
ADAGLENZADAG / LENZ
Capitalization295M185M159%
EBITDA-29.17M-117.98M25%
Gain YTD121.693-63.625-191%
P/E RatioN/A48.03-
Revenue103K21M0%
Total Cash62.8M258M24%
Total Debt6.85M673K1,018%
TECHNICAL ANALYSIS
Technical Analysis
ADAGLENZ
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 27 days ago
90%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADAG
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSCLX20.840.25
+1.21%
DFA International Social Cor Eq Instl
SRUIX16.83-0.02
-0.12%
Meeder Spectrum Institutional
GWGIX22.72-0.16
-0.70%
AMG GW&K Small Mid Cap Core I
RYVCX228.81-2.08
-0.90%
Rydex Energy Services C
GFDDX95.52-1.66
-1.71%
Invesco Global R5

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with MLTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
N/A
MLTX - LENZ
37%
Loosely correlated
N/A
CELC - LENZ
36%
Loosely correlated
N/A
BCYC - LENZ
36%
Loosely correlated
N/A
REPL - LENZ
34%
Loosely correlated
N/A
RCUS - LENZ
33%
Loosely correlated
+4.88%
More